Key result
Fetal growth restriction is linked to ~44% lower high-frequency power, reflecting suppressed cardiac vagal activity.
Why the study?
The study aimed to assess the association between fetal growth restriction and fetal heart rate variability in relation to fetal movements.
Does fetal growth restriction alter fetal heart rate variability during respiratory activity and quiescence compared to average for gestational age fetuses?
Cohort (n=36)
No
Does fetal growth restriction alter fetal heart rate variability during respiratory activity and quiescence compared to average for gestational age fetuses?
Fetal growth restriction is associated with impaired cardiac vagal activity during fetal quiescence, despite preserved respiratory sinus arrhythmia.
Answers are grounded in this paper and cite their sources.
May indicate suppressed vagal tone in FGR during quiescence; hypothesis-generating in small cohort, should not yet change practice.
The aim was to assess the association between fetal growth restriction (FGR) and fetal heart rate variability (FHRV) in relation to fetal movements. A prospective observational cohort study was performed. Non-invasive fetal electrocardiography (NI-FECG) allowed beat-to-beat assessments with <5% corrections of RR intervals. FHRV analyses included: Root mean square of successive RR interval differences (RMSSD), high frequency power (HF power), and low frequency power (LF power). Fetal movements were categorized by continuous ultrasound scanning. We enrolled 36 singleton pregnant women expecting a small fetus (< the 2.3 percentile of mean weight for gestational age) diagnosed by ultrasound, of whom 25 presented with a birthweight < the 2.3 percentile. Among these, 11 were excluded due to low quality NI-FECG recordings, leaving 14 women with 28 recordings eligible for inclusion in the analyses. The control group consisted of 22 healthy fetuses with birthweights between the 10th and the 90th percentile (average for gestational age [AGA]). In FGR fetuses the HRV response to respiratory activity was comparable to that of AGA fetuses. RMSSD (Ratio 1.54 [95% CI: 1.33; 1.79]) and HF power (Ratio 2.88 [95% CI: 2.12; 3.91]) increased, whereas LF/HF power (Ratio: 0.44 [95% CI: 0.31;0.63]) decreased. However, during fetal quiescence, FGR fetuses differed significantly from AGA fetuses. Compared to AGA fetuses, FGR fetuses displayed lower RMSSD (Ratio 0.77 (95% CI: 0.58; 1.02)) and HF power (Ratio 0.56 (95% CI:0.32; 0.98)). This reduction was associated with the severity of the FGR. In conclusion, FGR fetuses displayed a respiratory sinus arrhythmia (RSA) comparable to AGA fetuses; however, more important, parameters representing cardiac vagal activity were impaired in FGR fetuses during quiescence. RSA may constitute an intrinsic function of the cardiovascular system, which is unaffected by fetal compromise. However, the basic cardiac outflow assessed during fetal quiescence indicates a suppressed cardiac vagal activity in the FGR fetuses.
No takes yet. Share an insight, caveat, or question.
Zizzo et al. (2022) conducted a cohort in Fetal growth restriction (n=36). Fetal growth restriction vs. Average for gestational age (AGA) fetuses was evaluated on High frequency (HF) power during fetal quiescence (Ratio 0.56, 95% CI 0.32-0.98, p=0.04). Fetal growth restriction was associated with reduced high-frequency power during fetal quiescence compared to normal fetuses, indicating suppressed cardiac vagal activity.
Synapse has enriched 10 related papers. Consider them for comparative context: